Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Cushing Syndrome 6Hypertension 5Diabetes Mellitus, Type 2 5ACTH Syndrome, Ectopic 5Pituitary ACTH Hypersecretion 3Ovarian Neoplasms 3Fallopian Tube Neoplasms 3Adrenocortical Carcinoma 3Adrenal Cortex Neoplasms 3Prostatic Neoplasms 2Peritoneal Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Triple Negative Breast Neoplasms 1Pathologic Processes 1Ovarian Diseases 1Neoplasms by Site 1Hyperglycemia 1Glucose Intolerance 1Genital Neoplasms, Female 1Fallopian Tube Diseases 1Endometrial Neoplasms 1Endocrine System Diseases 1Carcinoma, Pancreatic Ductal 1Carcinoma, Ovarian Epithelial 1Adrenocortical Hyperfunction 1Adrenal Gland Diseases 1Adenocarcinoma 1

Interventions

relacorilant 1Tissue Banks 1Paclitaxel 1Filgrastim 1Carboplatin 1Blood Specimen Collection 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fallopian Tube Diseases × relacorilant × Clear all
NCT06906341 2026-04-14

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Corcept Therapeutics

Phase 2 Recruiting
270 enrolled
Gynecologic

Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡